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Abstract We have followed a combined proteomic approach to
identify proteins of Fasciola hepatica that could be involved in
host^parasite interactions. Using two-dimensional gel electro-
phoresis, far Western immunoblot and mass spectrometry anal-
yses, we have identi¢ed the enolase enzyme, present in the ex-
cretory/secretory materials of F. hepatica, as a human plas-
minogen-binding protein. This enzyme has an apparent molec-
ular weight of 47 kDa with pI ranging from 6.2 to 7.2. These
results suggest that enolase could act as a plasminogen receptor.
( 2004 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Fascioliasis is a disease caused by digenetic trematodes of
the genus Fasciola, of which Fasciola hepatica is the most
common. This species is well known as a £uke of livestock
causing signi¢cant economic losses with increasing importance
in human health, where there have been reported cases in the
¢ve continents [1]. Humans are usually infected by the inges-
tion of aquatic plants that harbor the infectious metacercar-
iae. The parasite excysts and migrates through the intestinal
wall to the peritoneal cavity and penetrates in the liver paren-
chyma causing considerable damage including extensive hem-
orrhaging and perforations [2,3]. F. hepatica secretes proteases
like cysteine proteases and cathepsins, which are believed to
play important roles in tissue penetration, immune evasion
and pathogenesis [3^7]. Other molecules identi¢ed in the ex-
cretion/secretion (E/S) materials of F. hepatica that could
modulate the host response include detoxifying enzymes like
protein disul¢de isomerase [8] and glutathione-S-transferases
(GSTs) [9].
Plasminogen is a 92 kDa plasma proenzyme of the serine
protease plasmin which plays important roles in processes like
¢brinolysis [10] and degradation of extracellular matrices [11].
A vast number of bacteria pathogens interact with plasmino-
gen enhancing their proteolytic activity and tissue damage
[12]. One of the best characterized cellular plasminogen recep-
tors in mammals is the glycolytic enzyme enolase [13,14]. Eno-
lase has been also localized on the surface of several patho-
gens like bacteria, fungi or protozoa [15], and very recently in
helminths [16]. This enzyme has been implicated in autoim-
mune diseases, and its utilization by pathogens in invading
host tissues is well documented [15]. Recent studies have in-
dicated that enolase present in the cell walls of Staphylococcus
aureus enhances the activation of plasminogen [17], favors
Streptococcus adherence to human pharyngeal cells [18], and
that, in Candida albicans, it promotes host endothelial inva-
sion by binding to plasmin(ogen) [19].
The enolase gene from F. hepatica was previously cloned in
a study aimed at identifying mRNA regions involved in trans-
splicing [20]. Here we present evidence suggesting that enolase
plays a role in the ¢brinolytic system based on its identi¢ca-
tion as a speci¢c human plasminogen interacting protein.
2. Materials and methods
2.1. E/S antigens of F. hepatica
Livers from naturally infected sheep were collected from a local
slaughterhouse and parasites were immediately removed and washed
exhaustively with pre-warmed phosphate bu¡ered saline pH 7.4
(PBS). Flukes were then placed at 37‡C for 12 h with slow agitation
in PBS containing 100 Wg/ml streptomycin (Sigma) at a ratio of 1 ml
per adult [21]. Thereafter the £ukes were removed and the culture
media centrifuged at 15 000Ug for 15 min at 4‡C. E/S products
were then precipitated using equal volumes of ice-cold 20% trichloro-
acetic acid (TCA) and solubilized in loading bu¡er for gel electropho-
resis. The protein content was measured by the protein assay method
(Bio-Rad) and adjusted to 10 mg/ml using an ultra¢ltration mem-
brane (YM-3, Millipore).
2.2. Two-dimensional (2D) electrophoresis
To carry out the 2D gel electrophoresis the protein samples were
solubilized at room temperature (RT) with a bu¡er containing 7 M
urea, 2 M thiourea, 4% 3[3-cholaminopropyl diethylammonio]-1-pro-
pane sulfonate (CHAPS) (w/v), 20 mM dithiothreitol (DTT) and 2%
(v/v) Biolytes 3-10 and bromophenol blue (all chemicals from Bio-
Rad), and were then applied onto a linear pH 6^8 ReadyStrip1
IPG strip (11 cm long, Bio-Rad). Isoelectric focusing was performed
on a Bio-Rad PROTEAN0 IEF cell at 20‡C using the following
program: (1) passive rehydration for 16 h; (2) 300 V for 1 h (step
and hold); (3) 4000 V for 2 h (linear voltage ramping until reaching
4000 V); and (4) 4000 V for 6.5 h (step and hold). After electrofocus-
ing, the strips were reduced (2% DTT) and then alkylated (2.5% io-
doacetamide) in equilibration bu¡er containing 6 M urea, 0.375 M
Tris pH 8.8, 2% sodium dodecyl sulfate (SDS) and 20% glycerol, and
the second dimension was performed using 10% polyacrylamide gels.
Proteins from SDS^polyacrylamide gel electrophoresis (PAGE) were
stained with Coomassie blue or electroblotted onto a nitrocellulose
membrane.
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2.3. Ligand blotting
For detecting plasminogen-binding activity, far Western blot assays
were performed after 2D electrophoresis. Gels were transferred to
nitrocellulose membranes in 20 mM Tris, 192 mM glycine, methanol
20% v/v, pH 8.3 as previously described [22]. Filters were stained with
Ponceau S (Sigma) for 10 min, and blocked for 3 h in 10 mM Tris^
HCl, pH 7.4, 150 mM NaCl (Tris bu¡ered saline, TBS) containing 5%
non-fat dry milk. After extensive washings with TBS containing 0.05%
Tween-20 (TBST), blots were incubated overnight at 4‡C with human
plasminogen (Fluka) at 35 Wg/ml in TBST containing 25 mM ethyl-
enediamine tetraacetic acid (EDTA) plus 1% bovine serum albumin
(BSA). After extensive washing in TBST, blots were then incubated in
TBST with 1% BSA containing 1:200 (v/v) monoclonal anti-human
plasminogen antibodies (Technoclone) for 2 h at RT. The bound anti-
body was detected by incubating blots 1 h at RT with goat anti-mouse
IgG horseradish peroxidase (HRP) conjugated (Bio-Rad) at 1:10 000
(v/v) in TBST with 1% BSA. Immune complexes were visualized using
Lumi-light Western blotting substrate (Roche) following the manufac-
turer’s instructions, and exposed to X-OMAT ¢lm (Kodak).
2.4. Western blot analysis
Immunoblot analysis with anti-K-enolase (from Streptococcus pneu-
moniae) antibody [23] (1:500 in PBST with 5% fat-free milk) was
performed after electroblotting a 2D gel onto a nitrocellulose mem-
brane. Bound antibody was detected using an anti-rabbit HRP-con-
jugated secondary antibody at 1:5000 in PBST. Filters were processed
as described above.
2.5. Mass spectrometry (MS) and identi¢cation
Each anti-plasminogen reactive spot (2D) was excised from the gel,
digested with sequencing grade trypsin (porcine, Promega) and excised
from the gel following the protocol of Shevchenko et al. [24] with
some modi¢cations. Samples were resuspended in 3 Wl of 0.1% TFA
(tri£uoroacetic acid) in preparation for MS. For matrix assisted laser
desorption/ionization-time of £ight (MALDI-TOF) MS, K-matrix (K-
cyano-4-hydroxycinnamic acid, Bruker Daltonics, Bruker) was pre-
pared at 0.3 g/l in ethanol:acetone 2:1 and DHB (2,5-dihydroxyben-
zoic acid, Bruker Daltonics, Bruker) at 5g/l in 33% acetonitrile, 0.1%
TFA. The internal standards used were Peptid Calibration Standard
(Bruker Daltonics, Bruker) at 10 pmol/Wl. Matrix and standards were
mixed in equal volumes and then added to an equal volume of sample
before 0.5 Wl of each was spotted onto the AnchorChip1 600/384 T F
target plate (Bruker Daltonics, Bruker) and allowed to dry. Samples
were analyzed on a Re£ex IV spectrometer (Bruker Daltonics, Bruker)
with delayed extraction operated in re£ection mode. Acquired spectra
were analyzed directly using XMASS (Bruker Daltonics, Bruker).
Database searches using the non-isotopic peptide masses were per-
formed using Biotools (Bruker Daltonics, Bruker) with MASCOT
software (http://www.matrixscience.com). Peptide modi¢cations in-
cluded in the search were carbamidomethyl (C) (¢xed) and oxidation
(M) (variable). All searches used the MSDB20020219 database and
were constrained to a peptide mass tolerance of 100 ppm.
3. Results
With the aim of characterizing proteins secreted by F. hepa-
tica that could be involved in host^parasite interactions, we
investigated the ability of F. hepatica E/S materials to bind
human plasminogen. E/S material was subjected to 2D gel
electrophoresis and transferred to nitrocellulose. Immobilized
spots were analyzed for their ability to bind human plasmin-
ogen. Interestingly, protein spots corresponding to a molecu-
lar mass of 47 kDa clearly bound human plasminogen in vitro
(Fig. 1A). These proteins were highly abundant in the F.
hepatica E/S material, as shown by Coomassie staining of
identical 2D gels (Fig. 1B). The binding was highly speci¢c,
since no other major protein spots exhibited plasminogen-
binding activity. As expected, human plasminogen was de-
tected as a 92 kDa band when using anti-plasminogen anti-
bodies (data not shown).
These 47 kDa protein spots were excised from the polyac-
rylamide gel, subjected to MS and peptide mass ¢ngerprint-
ing, and subsequently identi¢ed as F. hepatica enolase (Protein
database accession number A53665). This result indicated that
enolase is present at di¡erent isoelectric points (pI) ranging
from 6.2 to 7.2 (Fig. 1B). The peptide coverage of one of these
enolase spots (pI 7.0) reached 62.6% (Fig. 2). One of the pep-
tides identi¢ed by MS had a similar amino acid composition
(55.5% identity, 70.3% similarity) to a putative plasminogen-
binding motif recently reported for the S. pneumoniae enolase
[25] (Fig. 2).
To further con¢rm that the identity of the protein that
binds to human plasminogen is F. hepatica enolase, we next
performed an immunoblot assay after 2D electrophoresis of
F. hepatica E/S materials, using recombinant S. pneumoniae
K-enolase (47 kDa) as a positive control [23]. As shown in
Fig. 3, the same protein spots corresponding to a molecular
mass of 47 kDa that bound human plasminogen in vitro,
cross-reacted with antibodies directed against S. pneumoniae
K-enolase [23]. These spots exhibited the same apparent mo-
lecular weight as the recombinant enolase control (r-Eno).
4. Discussion
Following a proteomic approach, we have clearly shown
that F. hepatica E/S proteins bind human plasminogen in
vitro. Furthermore, we have identi¢ed F. hepatica enolase as
being responsible for this binding, suggesting that it may func-
tion as a plasminogen receptor. Enolase was identi¢ed using
Fig. 1. F. hepatica enolase present in E/S material binds plasmino-
gen in vitro. A: Far Western blot analysis after 2D gel electropho-
resis of F. hepatica E/S proteins run on an 11 cm pH 6^8 IPG strip
in the ¢rst dimension and then on gels of 10% SDS^PAGE in the
second dimension. B: Coomassie blue staining of an identical gel as
in A. The position of enolase is marked. Molecular weight markers
in kDa are indicated on the left.
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2D gel electrophoresis followed by MS and peptide mass ¢n-
gerprinting, and con¢rmed by Western blot analysis. Unfor-
tunately, at present this approach cannot be fully exploited in
F. hepatica because the sequence of the genome of this organ-
ism is not complete and therefore proteomic databases are
very limited [26].
The F. hepatica enolase is represented by a group of iso-
forms ranging in pI from 6.2 to 7.2. A previous study identi-
fying proteins present in E/S materials by 2D electrophoresis
associated the enzyme phosphopyruvate hydratase (enolase)
to a single spot of pI 6.56 and a theoretical molecular weight
of 46.2 kDa [27]. Our study con¢rms this apparent molecular
weight of 47 kDa, very similar to the theoretical molecular
weight reported for the puri¢ed enzyme from S. pneumoniae
that we used as a positive control [23,28]. Other enolases ex-
hibit di¡erences in weight, such as the recombinant Eno1
from Pneumocystis carinii that shows a molecular weight of
52 kDa [29]. We cannot discard di¡erent possibilities for the
size variation, like post-translational modi¢cations (i.e. glyco-
sylation), or even pre-translational modi¢cations like RNA
splicing. In fact, the F. hepatica enolase gene was cloned
when searching for repetitive regions of the F. hepatica
mRNA involved in trans-splicing [20].
Recent studies have shown similar plasminogen-binding ca-
pacity for enolases from other pathogenic organisms, includ-
ing bacteria like S. aureus [17], Streptococcus [23,28,30], fungi
like P. carinii [29] and helminths like Onchocerca volvulus [16].
These studies suggest an important role of this association for
the invasion of host tissues by the pathogenic agent [15]. In-
terestingly, recent reports have pointed to an enhanced acti-
vation of plasmin(ogen) upon interaction with the pathogen-
derived enolase [12,19]. Furthermore, a change in the cellular
localization of distinct enolase isoforms has been correlated
with pathogenicity in the parasitic protozoan Toxoplasma
gondii [31]. Moreover, Streptococcus G group surface enolase
seems to act as a spreading factor during tissue invasion [18].
The amino acid sequence of F. hepatica enolase lacks the
carboxy-terminal lysine residues of the plasminogen-binding
motif [20] which is found in pathogens like P. carinii [29]
and Streptococcus species [23,30,32]. But interestingly enough,
it does contain a region of 28 amino acids (amino acids 235^
253) (Fig. 2), which exhibits high homology with a novel plas-
minogen-binding domain recently identi¢ed in S. pneumoniae
[25], suggesting this region may be responsible for the binding.
Further studies should address these questions.
We still do not know whether other receptors for host ¢-
brinolytic proteins are present in the E/S material of F. hepa-
tica, but the evidence of plasminogen-binding molecules like
enolase opens this possibility. Future studies will also address
the potential immunogenicity of this and other E/S molecules.
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